Background
Methods
Patients
Cervical cancer | Endometrial cancer | Ovarian cancer | |
---|---|---|---|
Cases | 127 | 60 | 50 |
Mean age (years) | 51.9 (22–101) | 58.2 (23–81) | 48.8 (26–79) |
FIGO stage | |||
I | 61 | 46 | 15 |
II | 46 | 6 | 9 |
III | 17 | 6 | 20 |
IV | 3 | 2 | 6 |
Grade | |||
G1 | 40 | 35 | 6 |
G2 | 53 | 17 | 16 |
G3 | 31 | 8 | 26 |
Unclear | 3 | 2 | |
Histological type | |||
Squamous | 98 | ||
Adenocarcinoma | 29 | ||
Serous | 17 | ||
Mucinous | 10 | ||
Endometrioid | 60 | 11 | |
Clear cell | 6 | ||
Others | 6 | ||
Treatment | |||
ST | 32 | 38 | 6 |
RT | 44 | ||
CT | |||
ST+RT | 19 | 21 | |
ST+CT | 41 | ||
RT+CT+/- ST | 30 | 1 | 3a
|
No treatment | 2 |
DNA extraction and preparation of pooled DNA
DNA methylation analysis
Sodium-bisulfite treatment, MSP and sequencing
Data analysis and statistics
Results
Identification of CpG island methylation profiles in gynecologic cancers
Confirmation of hypermethylation for candidate genes in primary tumors
All subjects | DAPK | p16 | MGMT | PTEN | Any loci | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
+ | - | + | - | + | - | + | - | + | - | ||
Cases | 127 | 72 | 55 | 32 | 95 | 21 | 106 | 20 | 107 | 92 | 35 |
Mean age (yrs) | 51.9 | 52.8 | 50.7 | 53.5 | 51.4 | 49.8 | 52.3 | 52.9 | 51.7 | 53.0 | 48.9 |
P value(t-test) | 0.422 | 0.484 | 0.463 | 0.734 | 0.152 | ||||||
Stage | |||||||||||
I | 61 | 31 | 30 | 19 | 42 | 14 | 47 | 11 | 50 | 41 | 20 |
II | 46 | 27 | 19 | 11 | 35 | 7 | 39 | 7 | 39 | 36 | 10 |
III-IV | 20 | 14 | 6 | 2 | 18 | 0 | 20 | 2 | 18 | 15 | 5 |
P value(χ2 test) | 0.305 | 0.162 | 0.030c
| 0.688 | 0.431 | ||||||
Gradea
| |||||||||||
G1 | 40 | 25 | 15 | 13 | 27 | 7 | 33 | 8 | 32 | 31 | 9 |
G2–3 | 84 | 46 | 38 | 18 | 66 | 13 | 71 | 12 | 72 | 60 | 24 |
P value(χ2 test) | 0.416 | 0.183 | 0.775 | 0.419 | 0.475 | ||||||
Histological type | |||||||||||
SCC | 98 | 62 | 36 | 24 | 74 | 16 | 82 | 10 | 88 | 74 | 24 |
AC | 29 | 10 | 19 | 8 | 21 | 5 | 24 | 10 | 19 | 18 | 11 |
P value(χ2 test) | 0.006 | 0.736 | 0.907 | 0.002 | 0.155 | ||||||
Response to radiotherapyb
| |||||||||||
Radiosensitive | 44 | 30 | 14 | 12 | 32 | 8 | 36 | 5 | 39 | 36 | 8 |
Radioresistant | 19 | 9 | 10 | 3 | 16 | 2 | 17 | 3 | 16 | 11 | 8 |
P value(χ2 test) | 0.118 | 0.326 | 0.445 | 0.628 | 0.045 |
All subjects | CDH13 | APC | p16 | hMLH1 | Any loci | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
+ | - | + | - | + | - | + | - | + | - | ||
Case | 60 | 25 | 35 | 21 | 39 | 15 | 45 | 8 | 52 | 40 | 20 |
Mean age (yrs) | 58.2 | 59.2 | 57.5 | 58.4 | 58.1 | 59.3 | 57.9 | 62.2 | 57.6 | 59.3 | 56.0 |
P value (T-test) | 0.619 | 0.944 | 0.724 | 0.377 | 0.38 | ||||||
Stage | |||||||||||
I | 46 | 20 | 26 | 17 | 29 | 15 | 31 | 6 | 40 | 35 | 11 |
II-IV | 14 | 5 | 9 | 4 | 10 | 0 | 14 | 2 | 12 | 5 | 9 |
P value(χ2 test) | 0.606 | 0.565 | 0.014 | 0.905 | 0.005 | ||||||
Grade | |||||||||||
G1 | 35 | 12 | 23 | 10 | 25 | 11 | 24 | 1 | 34 | 22 | 13 |
G2–3 | 25 | 13 | 12 | 11 | 14 | 4 | 21 | 7 | 18 | 18 | 7 |
P value(χ2 test) | 0.17 | 0.217 | 0.174 | 0.007 | 0.459 |
All Subjects | p14 | BRCA1 | PTEN | p16 | Any loci | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
+ | - | + | - | + | - | + | - | + | - | ||
Cases | 49 | 12 | 37 | 8 | 41 | 4 | 45 | 9 | 40 | 25 | 24 |
Mean age (yrs) | 48.8 | 47.6 | 49.2 | 44.0 | 49.8 | 65.1 | 47.4 | 52.6 | 48.0 | 47.8 | 49.9 |
P value (T-test) | 0.7 | 0.239 | 0.006 | 0.321 | 0.559 | ||||||
Stage | |||||||||||
I-II | 24 | 9 | 15 | 2 | 22 | 2 | 22 | 4 | 20 | 12 | 12 |
III-IV | 25 | 3 | 22 | 6 | 19 | 2 | 23 | 5 | 20 | 13 | 12 |
P value (χ2 test) | 0.038 | 0.138 | 0.966 | 0.763 | 0.889 | ||||||
Gradea
| |||||||||||
G1–2 | 22 | 9 | 13 | 1 | 21 | 4 | 18 | 6 | 16 | 13 | 9 |
G3 | 25 | 3 | 22 | 7 | 18 | 0 | 25 | 3 | 22 | 12 | 13 |
P value (χ2 test) | 0.023 | 0.033 | 0.026 | 0.184 | 0.447 | ||||||
Histological type | 49 | ||||||||||
Serous | 17 | 2 | 15 | 6 | 11 | 1 | 16 | 3 | 14 | 11 | 6 |
Mucinous | 10 | 3 | 7 | 1 | 9 | 3 | 7 | 6 | 4 | 7 | 3 |
Endometrioid | 10 | 3 | 7 | 1 | 9 | 0 | 10 | 0 | 10 | 3 | 7 |
Clear-cell | 6 | 3 | 3 | 0 | 6 | 0 | 6 | 0 | 6 | 3 | 3 |
Others | 6 | 1 | 5 | 0 | 6 | 0 | 6 | 0 | 6 | 1 | 5 |
P value (χ2 test] | 0.08b
| 0.015c
| 0.023d
| <0.001e
| 0.015e
|